drugset / Trial / NCT02387619

The Pharmacokinetic Drug Interaction Between Rosuvastatin and Telmisartan/Amlodipine

NCT02387619 ↗

Phase 1 Completed 41 enrolled Jeil Pharmaceutical Co., Ltd.
RandomizedCrossoverOpen-labelTreatment

Summary

A randomized, open-label, multiple-dose, crossover study to investigate the pharmacokinetic drug interaction between rosuvastatin and telmisartan/amlodipine in healthy male volunteers

Timeline

Start
2015-02
Primary completion
2015-03
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Rosuvastatin Small molecule 20 mg —
Subject Telmisartan/Amlodipine Unknown 5 mg —
Subject Telmisartan/Amlodipine Unknown 40 mg —